Clearview Wealth Advisors LLC Amgen Inc Transaction History

Clearview Wealth Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $373,501 - $421,241	-1,664 Reduced 98.7%	22 $5,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $15,688 - $17,458	68 Added 4.2%	1,686 $410,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $5,481 - $6,064	-25 Reduced 1.52%	1,618 $391,000
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $16,507 - $18,890	83 Added 5.32%	1,643 $370,000
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $1,910 - $2,238	9 Added 0.58%	1,560 $332,000
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $44,380 - $49,236	-190 Reduced 10.91%	1,551 $378,000
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $47,710 - $55,599	215 Added 14.09%	1,741 $433,000
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $330,195 - $393,204	1,526 New	1,526 $351,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.